- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 13, 2025 | 658.57M sh |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | −$5.81M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | −$5.75M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $8.97M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $9.33M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $268.62K |
| Current Assets | Q2 2025 · Jun 30, 2024 | $664.21K |
| Total Assets | Q2 2025 · Dec 31, 2024 | $276.6K |
| Total Assets | Q2 2025 · Jun 30, 2024 | $713.01K |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 423.47M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 408.57M sh |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$644.48K |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.00 |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $52.75K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $79.74K |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$1.2M |
| Net Income restated | Q2 2025 · Dec 31, 2023 | −$1.53M |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$339.94K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$658.83K |